Search Results
Daratumumab and isatuximab in the treatment of multiple myeloma
Daratumumab vs isatuximab in the treatment of multiple myeloma
Choosing between isatuximab & daratumumab in multiple myeloma
What is isatuximab? And how does it compare with daratumumab?
Robert M. Rifkin, MD, FACP, explains how isatuximab differs from daratumumab
All About Sarclisa (Isatuximab) #myeloma
Dr. Harrison on Subcutaneous Daratumumab and Isatuximab in Myeloma
Isatuximab for multiple myeloma - promising results and next steps
Daratumumab in the treatment of multiple myeloma
Anti-CD38 immunotherapy treatment for multiple myeloma
Treatment options for patients with multiple myeloma who are resistant to daratumumab
CD38 antibodies under investigation for myeloma: isatuximab, MOR202 & TAK-079
